Organoids are helping scientists push the boundaries for in vitro study of the intestinal epithelium. A key benefit of intestinal organoid cultures is that they are amenable to genome editing, such as by CRISPR-Cas9, an RNA-guided technology that has revolutionized genome editing due to its ease and efficiency. Explore our protocols and resources for information on how to perform high-efficiency CRISPR-Cas9 genome editing of intestinal organoids to develop better in vitro disease models and study organ development.
For detailed protocols developed specifically for our products, please consult the Product Information Sheet or enter the product keyword or catalog number below.
StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not
share your email address with third parties. StemCell Technologies Inc. will use your email address to
confirm your identity and send you newsletters, transaction-related emails, promotional and customer
service emails in accordance with our privacy policy. You can change
your email preferences at any time.